DeepMind digital biology venture applying next-generation AI models to reimagine drug design
Conducts strategic drug discovery partnerships and publishes peer-reviewed research
Founded by Nobel laureate Demis Hassabis as a spin-off of DeepMind research, Isomorphic Labs views biology as an information system. Leveraging multimodal architectures, it predicts molecular interactions and binding mechanics across drug targets, radically accelerating the therapeutic discovery timeline.